<SEC-DOCUMENT>0000950170-25-019188.txt : 20250212
<SEC-HEADER>0000950170-25-019188.hdr.sgml : 20250212
<ACCEPTANCE-DATETIME>20250212194752
ACCESSION NUMBER:		0000950170-25-019188
CONFORMED SUBMISSION TYPE:	144
PUBLIC DOCUMENT COUNT:		1
FILED AS OF DATE:		20250212
DATE AS OF CHANGE:		20250212

SUBJECT COMPANY:	

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Travere Therapeutics, Inc.
		CENTRAL INDEX KEY:			0001438533
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		ORGANIZATION NAME:           	03 Life Sciences
		IRS NUMBER:				262383102
		STATE OF INCORPORATION:			CA
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		144
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	001-36257
		FILM NUMBER:		25616723

	BUSINESS ADDRESS:	
		STREET 1:		3611 VALLEY CENTRE DR
		STREET 2:		SUITE 300
		CITY:			SAN DIEGO
		STATE:			CA
		ZIP:			92130
		BUSINESS PHONE:		888-969-7879

	MAIL ADDRESS:	
		STREET 1:		3611 VALLEY CENTRE DR
		STREET 2:		SUITE 300
		CITY:			SAN DIEGO
		STATE:			CA
		ZIP:			92130

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Retrophin, Inc.
		DATE OF NAME CHANGE:	20130220

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Desert Gateway, Inc.
		DATE OF NAME CHANGE:	20080625

REPORTING-OWNER:	

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Heerma Peter
		CENTRAL INDEX KEY:			0001789617
		ORGANIZATION NAME:           	

	FILING VALUES:
		FORM TYPE:		144

	MAIL ADDRESS:	
		STREET 1:		C/O TRAVERE THERAPEUTICS, INC.
		STREET 2:		3611 VALLEY CENTRE DRIVE, SUITE 300
		CITY:			SAN DIEGO
		STATE:			CA
		ZIP:			92130
</SEC-HEADER>
<DOCUMENT>
<TYPE>144
<SEQUENCE>1
<FILENAME>primary_doc.xml
<TEXT>
<XML>
<?xml version="1.0" encoding="UTF-8"?><edgarSubmission xmlns="http://www.sec.gov/edgar/ownership" xmlns:xsd="http://www.w3.org/2001/XMLSchema" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<headerData>
<submissionType>144</submissionType>
<filerInfo>
<filer>
<filerCredentials>
<cik>0001789617</cik>
<ccc>XXXXXXXX</ccc>
</filerCredentials>
</filer>
<liveTestFlag>LIVE</liveTestFlag>
</filerInfo>
</headerData>
<formData>
<issuerInfo>
<issuerCik>0001438533</issuerCik>
<issuerName>Travere Therapeutics, Inc.</issuerName>
<secFileNumber>001-36257</secFileNumber>
<issuerAddress>
<street1 xmlns="http://www.sec.gov/edgar/common">3611 Valley Centre Dr.</street1>
<street2 xmlns="http://www.sec.gov/edgar/common">Suite 300</street2>
<city xmlns="http://www.sec.gov/edgar/common">San Diego</city>
<stateOrCountry xmlns="http://www.sec.gov/edgar/common">CA</stateOrCountry>
<zipCode xmlns="http://www.sec.gov/edgar/common">92130</zipCode>
</issuerAddress>
<issuerContactPhone>888-969-7879</issuerContactPhone>
<nameOfPersonForWhoseAccountTheSecuritiesAreToBeSold>Peter Heerma</nameOfPersonForWhoseAccountTheSecuritiesAreToBeSold>
<relationshipsToIssuer>
<relationshipToIssuer>Officer</relationshipToIssuer>
</relationshipsToIssuer>
</issuerInfo>
<securitiesInformation>
<securitiesClassTitle>Common</securitiesClassTitle>
<brokerOrMarketmakerDetails>
<name>Morgan Stanley Smith Barney</name>
<address>
<street1 xmlns="http://www.sec.gov/edgar/common">3 Edison Drive</street1>
<city xmlns="http://www.sec.gov/edgar/common">Alpharetta</city>
<stateOrCountry xmlns="http://www.sec.gov/edgar/common">GA</stateOrCountry>
<zipCode xmlns="http://www.sec.gov/edgar/common">30005</zipCode>
</address>
</brokerOrMarketmakerDetails>
<noOfUnitsSold>2568</noOfUnitsSold>
<aggregateMarketValue>60425.59</aggregateMarketValue>
<noOfUnitsOutstanding>78049928</noOfUnitsOutstanding>
<approxSaleDate>02/12/2025</approxSaleDate>
<securitiesExchangeName>NASDAQ</securitiesExchangeName>
</securitiesInformation>
<securitiesToBeSold>
<securitiesClassTitle>Common</securitiesClassTitle>
<acquiredDate>02/10/2025</acquiredDate>
<natureOfAcquisitionTransaction>Performance Restricted Stock Unit Vesting</natureOfAcquisitionTransaction>
<nameOfPersonfromWhomAcquired>Issuer</nameOfPersonfromWhomAcquired>
<isGiftTransaction>N</isGiftTransaction>
<amountOfSecuritiesAcquired>2568</amountOfSecuritiesAcquired>
<paymentDate>02/10/2025</paymentDate>
<natureOfPayment>Compensation</natureOfPayment>
</securitiesToBeSold>
<nothingToReportFlagOnSecuritiesSoldInPast3Months>N</nothingToReportFlagOnSecuritiesSoldInPast3Months>
<securitiesSoldInPast3Months>
<sellerDetails>
<name>Peter Heerma</name>
<address>
<street1 xmlns="http://www.sec.gov/edgar/common">3611 Valley Centre Drive</street1>
<street2 xmlns="http://www.sec.gov/edgar/common">Suite 300</street2>
<city xmlns="http://www.sec.gov/edgar/common">San Diego</city>
<stateOrCountry xmlns="http://www.sec.gov/edgar/common">CA</stateOrCountry>
<zipCode xmlns="http://www.sec.gov/edgar/common">92130</zipCode>
</address>
</sellerDetails>
<securitiesClassTitle>Common</securitiesClassTitle>
<saleDate>02/11/2025</saleDate>
<amountOfSecuritiesSold>3074</amountOfSecuritiesSold>
<grossProceeds>76850</grossProceeds>
</securitiesSoldInPast3Months>
<securitiesSoldInPast3Months>
<sellerDetails>
<name>Peter Heerma</name>
<address>
<street1 xmlns="http://www.sec.gov/edgar/common">3611 Valley Centre Drive</street1>
<street2 xmlns="http://www.sec.gov/edgar/common">Suite 300</street2>
<city xmlns="http://www.sec.gov/edgar/common">San Diego</city>
<stateOrCountry xmlns="http://www.sec.gov/edgar/common">CA</stateOrCountry>
<zipCode xmlns="http://www.sec.gov/edgar/common">92130</zipCode>
</address>
</sellerDetails>
<securitiesClassTitle>Common</securitiesClassTitle>
<saleDate>02/03/2025</saleDate>
<amountOfSecuritiesSold>5166</amountOfSecuritiesSold>
<grossProceeds>103934.09</grossProceeds>
</securitiesSoldInPast3Months>
<securitiesSoldInPast3Months>
<sellerDetails>
<name>Peter Heerma</name>
<address>
<street1 xmlns="http://www.sec.gov/edgar/common">3611 Valley Centre Drive</street1>
<street2 xmlns="http://www.sec.gov/edgar/common">Suite 300</street2>
<city xmlns="http://www.sec.gov/edgar/common">San Diego</city>
<stateOrCountry xmlns="http://www.sec.gov/edgar/common">CA</stateOrCountry>
<zipCode xmlns="http://www.sec.gov/edgar/common">92130</zipCode>
</address>
</sellerDetails>
<securitiesClassTitle>Common</securitiesClassTitle>
<saleDate>01/22/2025</saleDate>
<amountOfSecuritiesSold>1584</amountOfSecuritiesSold>
<grossProceeds>30002.25</grossProceeds>
</securitiesSoldInPast3Months>
<remarks>Represents the number of shares required to be sold by the Reporting Person to cover the tax withholding obligation in connection with the settlement of vested performance restricted stock units. This sale is mandated by the Issuer's election under its equity incentive plans to require the Reporting Person to fund this tax withholding obligation by completing a "sell to cover" transaction with a brokerage firm designated by the Issuer. This sale does not represent a discretionary trade by the Reporting Person.</remarks>
<noticeSignature>
<noticeDate>02/12/2025</noticeDate>
<signature>/s/ Elizabeth E. Reed as attorney-in-fact for Peter Heerma</signature>
</noticeSignature>
</formData>
</edgarSubmission>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
